Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAC in Alzheimer's Disease or Vascular Dementia
NCT02467413Phase 2Withdrawn
- Sponsor
- Botanicure
- Start
- Jan 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of benzalkonium chloride in Alzheimer's disease (AD), vascular dementia, sponsored by Botanicure. Planned start Jan 2017; status: withdrawn.
02
Drugs
benzalkonium chloride
03
Conditions
Alzheimer's disease (AD)vascular dementia
Beyond the preview
Go deeper on NCT02467413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467413.